Siemens Atellica CH LDL Cholesterol analyzer reagent carryover issue
Siemens is recalling Atellica CH analyzers due to potential reagent carryover that can cause falsely elevated results in cholesterol, bilirubin, and liver enzyme tests. This could affect the accuracy of patient laboratory results.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II diagnostic device recall involving potential analytical errors in critical laboratory tests. Although no illnesses or injuries have been reported, the potential for measurement bias in cholesterol and liver function testing represents a risk-of-harm scenario that could affect patient clinical decisions.
Plain-English summary
Siemens Healthcare Diagnostics is recalling the Atellica CH LDL Cholesterol analyzer (Atellica CH 930) used in clinical laboratories. The device is an in vitro diagnostic system for quantitatively measuring LDL cholesterol and related analytes in human blood serum and plasma.
The recall is due to potential for reagent carryover on the analyzer that can result in a positive bias (falsely elevated results). This bias could affect patient samples, quality control samples, and calibration materials. The issue impacts measurement of LDL Cholesterol, Total Bilirubin, Gamma-Glutamyl Transferase (GGT), and HDL Cholesterol on the same device.
Approximately 6,733 units have been distributed nationwide in the United States and internationally to Taiwan, Uruguay, and Vietnam. All lot numbers of the device are included in this recall.
The recalled product
- Product
- Atellica CH LDL Cholesterol- In vitro diagnostic use in the quantitative determination of LDL cholesterol in human serum and plasma (lithium heparin, EDTA, sodium heparin Test Code: LDLC Siemens Material Number (SMN): 11537214
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Affected units
- 6,733
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Unique Device Identification (UDI): 00630414611037 All Lot Numbers
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 4 recalled by Siemens Healthcare Diagnostics, Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc.
See all →- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
Same hazard · reagent carryover
See all →- HighDiagnostic reagent kit recall: potential test result inaccuracy
FDA (Devices) · 2023-09-06
- HighSiemens Atellica CH diagnostic reagent carryover may cause false laboratory test results
FDA (Devices) · 2023-09-06
- HighLaboratory diagnostic test may produce inaccurate results from reagent carryover
FDA (Devices) · 2023-09-06
- ModerateSiemens Atellica CH Total Protein II Recalled for Reagent Carryover
FDA (Devices) · 2023-09-06
- HighAtellica CH Triglycerides_2 Reagent Recalled Due to Magnesium Test Interference
FDA (Devices) · 2023-09-06